3:26 PM
 | 
Nov 13, 2018
 |  BC Extra  |  Company News

Management tracks: Anchiano, ContraFect

Cancer company Anchiano Therapeutics Inc. (Tel Aviv:ANCN) appointed Stephen Hoffman chairman. He is CEO of Aerpio Pharmaceuticals Inc. (OTCQB:ARPO). Anchiano also named Robert Connelly a director. He was a venture partner at Flagship Pioneering and CEO of Axcella Health Inc. (Cambridge, Mass.).

Infectious disease company ContraFect Corp. (NASDAQ:CFRX) promoted SVP of Finance Michael Messinger to CFO.

Infectious disease vaccine company Novavax Inc. (NASDAQ:NVAX) promoted Jody Lichaa to SVP...

Read the full 319 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >